Event by Lhasa limited with participation of Sr. Froetschl from Federal Institute of Drugs and Medical Devices (Germany) & Dr. Musso from Pfizer.
Introduction to ICH M7 guidelines
Dr Roland Froetschl, from the Federal Institute for Drugs and Medical Devices, will open the webinar by introducing the ICH M7 guidelines and explain how expert-based and statistical systems can be used together to classify mutagenic impurities. Roland will also discuss the benefits of using in silico methods for assessing new drug candidates.
Industry case study:
Dr Alyssa Musso, Global Risk Assessment Services Toxicologist within Drug Safety Research and Development at Pfizer will demonstrate a detailed case study showcasing how Pfizer implements Derek Nexus and Sarah Nexus for ICH M7 submissions.